A new therapeutic route for combatting treatment-resistant cancer has been identified with the discovery that melanoma cells fight anti-cancer drugs by changing their internal skeleton.
List view / Grid view
Queen Mary University of London
Filter the results
A study has revealed that activation of syndecan-4 sensory protrusions extending from cells may be a future target for cancer therapy.
This article highlights some of the most recent drug target discoveries that could be used to develop and design a treatment for pancreatic cancer.
A study has demonstrated that a novel vaccine design for pancreatic cancer has been successful in mice, doubling survival time.
Scientists have found a way to target and knock out a protein which is widely involved in pancreatic cancer cell growth, survival and invasion.
Immunotherapy using 'educated' killer cells could be a potential cure for pancreatic cancer, with researchers eliminating all signs of cancer from mice...
Mice with pancreatic cancer that were treated with CBD alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone...
A cure for haemophilia is one step closer, following results of a gene therapy trial led by the NHS in London.
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
Scientists have shown that it is possible to incorporate DNA analysis into antenatal screening for three serious chromosome disorders including Down's syndrome...
Researchers have shown that starving a childhood brain tumour of the amino acid glutamine may improve the effect of chemotherapy...
Scientists have uncovered a way to ‘program’ immune cells to cause less damage to the body, by tapping into a ‘broken’ chemical pathway in inflammation.
Women who receive human papillomavirus (HPV) testing, in addition to a Pap smear, receive a faster, more complete diagnosis of possible cervical pre-cancer, according to a study of over 450,000 women by Queen Mary University of London (QMUL) and the University of New Mexico (UNM) Comprehensive Cancer Center.
Patients who have aggressive prostate cancer could be identified by a highly accurate and simple blood test, according to a new study.